NFA
XBIT icon

Nationwide Fund Advisors’s XBiotech XBIT Stock Holding History

Nationwide Fund Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,143
Closed -$44K – 2148
2017
Q3 		$44K Hold
10,143
– – ﹤0.01% 3055
2017
Q2 		$48K Hold
10,143
– – ﹤0.01% 3060
2017
Q1 		$167K Sell
10,143
-1,149
-10% -$15K ﹤0.01% 2665
2016
Q4 		$114K Hold
11,292
– – ﹤0.01% 2831
2016
Q3 		$152K Hold
11,292
– – ﹤0.01% 2757
2016
Q2 		$236K Buy
11,292
+8,698
+335% +$126K ﹤0.01% 2532
2016
Q1 		$25K Sell
2,594
-35,775
-93% -$296K ﹤0.01% 3083
2015
Q4 		$417K Buy
38,369
+35,775
+1,379% +$457K ﹤0.01% 2197
2015
Q3 		$39K Hold
2,594
– – ﹤0.01% 3061
2015
Q2 		$47K Buy
+2,594
New +$53.8K ﹤0.01% 3106

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Nationwide Fund Advisors's XBIT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of XBiotech (XBIT) in Q4 2017, closing a stake of 10,143 shares — an estimated $44K sold.

Nationwide Fund Advisors first reported a position in XBIT in Q2 2015 and held it in 10 quarters. The position peaked at $417K in Q4 2015. 44 funds tracked by Wall St. Rank hold XBIT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining XBiotech position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 10,143 XBiotech shares in Q4 2017, an estimated $44K.
  • Nationwide Fund Advisors first reported a position in XBiotech in Q2 2015 and held it in 10 quarters.
  • Nationwide Fund Advisors's XBiotech position peaked at $417K in Q4 2015.
  • 44 funds tracked by Wall St. Rank held XBiotech as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.